Nkarta announces june 2021 investor conference schedule

South san francisco, calif., may 25, 2021 (globe newswire) -- nkarta, inc. (nasdaq: nktx), a biopharmaceutical company developing engineered natural killer (nk) cell therapies to treat cancer, today announced its participation at this upcoming investor conference:

NKTX Ratings Summary

NKTX Quant Ranking